The persistence of antibodies in ESRD patients 12 months after the BNT162B2 vaccine booster dose.
End-stage renal disease (ESRD) patients undergoing haemodialysis have been reported to have impaired humoral response after coronavirus disease 2019 vaccination. However, most studies focus on one antibody profile or one-time point only. Here, we longitudinally investigate the antibody response towa...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , , |
|---|---|
| التنسيق: | مقال |
| اللغة: | English |
| منشور في: |
UniKL Royal College of Medicine Perak (UniKL RCMP)
2024
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | http://irep.iium.edu.my/113313/7/113313_The%20persistence%20of%20antibodies%20in%20ESRD%20patients%2012%20months.pdf http://irep.iium.edu.my/113313/ https://www.ajmhsrcmp.org/#page/1 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|